You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創醫療(00853.HK):脈通醫療科技(嘉興)獲戰投1億元
格隆匯 01-08 20:34

格隆匯1月8日丨微創醫療(00853.HK)公吿,於2021年1月8日,目標公司脈通醫療科技(嘉興)有限公司及附屬公司(均為集團全資附屬公司)與望道通生物技術及投資者訂立協議,據此,望道通生物技術及投資者將向目標公司額外注資合計人民幣1億元。

目標公司為一間於中國成立的有限責任公司,主要從事醫療器械的材料及部件(包括醫用高分子管材、醫用紡織品,以及醫用金屬管材)的研究、開發、生產和銷售。

望道通生物技術為一間於中國成立的有限責任公司,主要從事投資控股業務。望道通生物技術由執行董事常兆華博士全資擁有及就上市規則第14A章而言為公司的關連人士。

公司表示,目標公司主要為醫療器械產品提供材料和部件,其研發、商業化和擴大生產規模等需要大量資金投入。協議項下擬進行的增資將為目標公司提供額外資本,從而為其發展計劃的實施和執行及把握目標公司的增長機會提供資金。集團採取一項鼓勵僱員積極參與業務投資的策略,使僱員可以在業務中擁有個人權益並分享成果。協議乃為鼓勵僱員積極參與此項投資而訂立。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account